share_log

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Welgus Howard G.

SEC ·  Nov 6 05:51

Summary by Futu AI

Howard G. Welgus, associated with Arcutis Biotherapeutics, Inc., completed a sale of 10,000 shares of common stock on November 1, 2024. The transaction was carried out in the open market with the shares sold at a price of $8.6541 each, resulting in a total sale value of $86,541. Following the sale, Welgus holds a total of 171,944 shares in the company directly.
Howard G. Welgus, associated with Arcutis Biotherapeutics, Inc., completed a sale of 10,000 shares of common stock on November 1, 2024. The transaction was carried out in the open market with the shares sold at a price of $8.6541 each, resulting in a total sale value of $86,541. Following the sale, Welgus holds a total of 171,944 shares in the company directly.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated